Capricor Therapeutics's total assets for Q3 2025 were $126.44M, a decrease of -5.34% from the previous quarter. CAPR total liabilities were $42.57M for the fiscal quarter, a 48.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.